Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Hepatitis B and the delta agent].

W Jilg, M Roggendorf, G Zoulek

    Fortschritte Der Medizin
    |February 9, 1984
    PubMed
    Summary
    This summary is machine-generated.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    A novel deletion mutant of hepatitis B virus surface antigen.

    Journal of medical virology·1999
    Same author

    Prevalence of human T-cell lymphotropic virus infections in Germany.

    Journal of medical virology·1994
    Same author

    [A new variant of the simian T-lymphotropic retrovirus type I (STLV-IF) in the Sukhumi colony of hamadryas baboons].

    Voprosy virusologii·1993
    Same author

    Production of human cloned antibodies specific for hepatitis D virus-encoded small and large protein.

    Journal of hepatology·1993
    Same author

    Principal neutralizing domain of HIV-1 is highly immunogenic when expressed on the surface of hepatitis B core particles.

    Vaccine·1993
    Same author

    The immune response to different doses of inactivated hepatitis A vaccine.

    Journal of hepatology·1993
    Same journal

    [More information--less pain. Procedure in pain following amputation of limbs. Brachial plexus injury and nerve root avulsion. Interview by Susanne Kammerer].

    Fortschritte der Medizin·1999
    Same journal

    [Galenic alternatives to unstable tocopherol acetate. "Smeared" or cheated?--Vitamin E in facial ointments].

    Fortschritte der Medizin·1999
    Same journal

    [Gene diagnosis in the hand of the physician].

    Fortschritte der Medizin·1999
    Same journal

    [Is non-toxic cancer therapy through biotechnology a possibility?].

    Fortschritte der Medizin·1999
    Same journal

    [Smoking withdrawal in practice and clinic].

    Fortschritte der Medizin·1999
    Same journal

    [The future of pancreas diagnosis. An exclusive training service of the Gastro-Ligue for dermatologists].

    Fortschritte der Medizin·1999
    See all related articles

    Hepatitis delta virus (HDV) is a defective RNA virus requiring hepatitis B virus (HBV) for replication. Infection can cause biphasic or acute hepatitis, progressing to chronic forms, particularly in at-risk groups.

    Area of Science:

    • Virology
    • Hepatology

    Context:

    • Hepatitis delta virus (HDV) is a unique RNA virus.
    • HDV requires hepatitis B virus (HBV) for its replication and spread.
    • HDV infection occurs through parenteral transmission, often alongside or superimposed on HBV infection.

    Purpose:

    • To describe the characteristics of Hepatitis delta virus (HDV) infection.
    • To outline the transmission routes and clinical outcomes of HDV infection.
    • To identify populations at risk and diagnostic considerations for HDV.

    Summary:

    • HDV is a defective RNA virus dependent on HBV for helper function.
    • Transmission occurs parenterally, either with HBV or superimposed on chronic HBV infection.
    • Clinical presentations include biphasic hepatitis or acute delta hepatitis progressing to chronic delta hepatitis, especially in drug addicts, hemophiliacs, and polytransfused patients.

    Related Experiment Videos

    Impact:

    • Highlights the diagnostic suspicion for HDV in specific patient groups.
    • Emphasizes the lack of specific HDV therapy.
    • Stresses the importance of hepatitis B vaccination as a prophylactic measure against HDV.